HealthQuill WHO
Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a secondary goal of a ‘high’ viral suppression rate in adults.
Drugs Health Pharma

Gilead, Merck’s HIV experimental drug scores ‘high’ on viral suppression

Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a.

Read More
Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future climate-related health threats, according to a  statement from the University of Glasgow.
Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.

Read More
India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise in coronary artery diseases, according to UK-based data analytics and consulting company, GlobalData.
Drugs Medical Pharma

Coronary drug-eluting stent market to grow 4% in India till 2033: Report

India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.

Read More
Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally, according to a World Health Organization report.
Drugs Health Pharma

Vaccines against pathogens can cut global antibiotic usage by 22%

Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally,.

Read More
Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years, according to the Pan American Health Organization.
Health Medical Pharma

Dengue cases at an all-time high in Americas Region: PAHO report

Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years,.

Read More
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season compared to 94.1% in the first and 64.2% in the second.
Drugs Health Pharma

GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year

GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season.

Read More
Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.
Drugs Health Pharma

Johnson & Johnson stops mid-stage trial of drug for dengue prevention

Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.

Read More
About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the WHO.
Drugs Health Pharma

One in seven adolescents globally suffer from mental health disorders 

About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the.

Read More
The West Asian Hashemite Kingdom of Jordan has been designated as the first country in the world to be verified by the WHO as having eliminated leprosy.
Drugs Health Pharma

Jordan becomes first WHO-verified nation in the world to eliminate leprosy

The West Asian Hashemite Kingdom of Jordan has been designated as the first country in the world to be verified by the WHO.

Read More
Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.
Drugs Health Pharma

Antimicrobial resistance may kill 39.1 million people by 2050: GRAM

Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.

Read More